Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer.

scientific article published in January 2007

Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S12032-007-0035-7
P698PubMed publication ID17917094

P50authorMustafa BenekliQ56435446
P2093author name stringSuleyman Buyukberber
Ugur Coskun
Mustafa Dikilitas
Aytug Uner
Ali Osman Kaya
Banu Ozturk
Emel Yaman
Ramazan Yildiz
Deniz Yamac
Ozlem Er
Mevlude Polat
P2860cites workCapecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108.Q46538590
Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: post hoc analysis of a large phase II studyQ46648452
Capecitabine plus oxaliplatin (xelox) versus protracted 5-fluorouracil venous infusion plus oxaliplatin (pvifox) as first-line treatment in advanced colorectal cancer: a GOAM phase II randomised study (FOCA trial)Q56996728
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of CanadaQ27860904
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialQ28036747
Cancer statistics, 2007Q29547293
A phase II study of capecitabine plus oxaliplatin (XELOX): a new first-line option in metastatic colorectal cancerQ33366181
XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancerQ33370632
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancerQ33913953
XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancerQ33978749
Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III studyQ34514696
Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Pro: The CapeOx regimen is preferred over FOLFOX.Q36259006
Treatment of advanced colorectal carcinoma with oxaliplatin and capecitabine: a phase II trialQ44457418
Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancerQ44572711
Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE StudyQ46473453
P433issue4
P921main subjectcolorectal cancerQ188874
capecitabineQ420207
oxaliplatinQ422327
P304page(s)431-435
P577publication date2007-01-01
P1433published inMedical OncologyQ2152666
P1476titleCapecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer
P478volume24

Reverse relations

cites work (P2860)
Q42059647Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer
Q43227528Bevacizumab plus irinotecan-based therapy in metastatic colorectal cancer patients previously treated with oxaliplatin-based regimens.
Q38121955DNA interstrand cross-link repair: understanding role of Fanconi anemia pathway and therapeutic implications
Q38081864Management of advanced colorectal cancer, Part 1.
Q37839084XELOX in colorectal cancer: a convenient option for the future?

Search more.